Board Name | Posts By CraigT23 | Post Created |
---|---|---|
MDIN MedGen Inc | That makes 2 of us =) | 03/03/2014 5:41:21 PM |
MDIN MedGen Inc | Can't wait to buy some + curious ho | 02/23/2014 10:49:29 AM |
MDIN MedGen Inc | Could be GW Pharma | 02/23/2014 8:59:59 AM |
MDIN MedGen Inc | Big unknown is how the supply and d | 02/09/2014 6:22:42 PM |
MDIN MedGen Inc | No confirmations, but you will prob | 02/08/2014 8:03:50 AM |
MDIN MedGen Inc | My shares are strapped down | 02/07/2014 10:35:49 AM |
MDIN MedGen Inc | Hoping our acquisition partners are | 02/03/2014 8:00:39 PM |
MDIN MedGen Inc | Great time for some news | 01/22/2014 8:12:01 PM |
MDIN MedGen Inc | Need some Ask slaps the way these r | 01/22/2014 3:03:47 PM |
MDIN MedGen Inc | Let's hope for a little excitement | 01/21/2014 6:49:04 AM |
MDIN MedGen Inc | Agree - looks good. Just took a g | 01/19/2014 10:14:08 PM |
MDIN MedGen Inc | Just 10 left! | 01/19/2014 10:02:17 PM |
MDIN MedGen Inc | I'm here...long and strong | 01/18/2014 9:35:22 PM |
Recent Articles
- Graybar Expands STAR Centers for Enhanced Logistics Solutions
- BiotechBeauty®: Innovating Clean Makeup Through Science
- Whitley Penn Welcomes James McNamara as New Tax Partner
- Credilab's Robust Growth: A Leap to US$35 Million Loan Book
- Exploring Gold's Potential Surge Amid Political Pressures
- Investing in Oversold Stocks: Key Players to Watch Now
- Experience the Thrill of the 2027 Mediterranean Solar Eclipse
- Exploring WisdomAI's Innovative Proactive Agents for Analytics
- Strategic Recapitalization Analysis for Green Infrastructure Partners
- Syndax Pharmaceuticals: Unlocking Potential in Leukemia Treatments
- Insights into the Future of Federal Funding for Innovators
- Credilab’s Journey: From Start to $35 Million Loan Book Growth
- Gap Inc. Strengthens Retail Footprint with New Ventures
- Analyst Revisions for Figma’s Earnings Reflect Industry Trends
- Exploring Current Market Sentiment Around Amazon Stock
- Understanding the Dynamics of T Stamp's Short Interest Trends
- Interoil's Joint Venture with Petrominera Faces Termination
- Investor Sentiment Towards IBM: A Deep Dive Analysis
- Macy's Navigates Challenges with New Strategy and Earnings Boost
- Sucro and Santander Collaborate to Establish Caribbean Sugar Refinery
- Next Generation Management Corp. Embraces Digital Commerce Shift
- Lucid Group Launches New Campaign Amidst Investor Concerns
- SQDC's Financial Performance Shows Robust Growth in Q1
- PagerDuty's Q2 Earnings: Insights and Analyst Reactions
- American Eagle Outfitters Raises Forecasts After Strong Q2
- Next Generation Management Corp's Vision for Digital Sales Expansion
- Adrian Lucero Expands Total Blinds with Phantom Screens
- Hennick Group Expands Holdings with Signature Retail Acquisition
- Stock Market Insights: Nasdaq Rises While SAIC Faces Challenges
- Understanding the Current Downturn of Lucid Group's Stock
- Cryptocurrency Market Trends: A Deep Dive into Major Players
- Investigation Launched into AGCO Corporation for Investor Rights
- New Legal Battle: NCLA Challenges SEC's Practices
- Optimistic Analysts Raise Macy's Stock Forecasts After Q2
- Evaluating Mastercard Inc's Earnings Performance and P/E Ratio
- Bullish Trends in Alphabet's Options Trading Activity
- Exploring Booking Holdings' Options Trading Dynamics
- Exploring Current Options Trends for Palantir Technologies
- Analysts Revise Predictions for Campbell’s After Strong Q4 Results
- Dollar Tree Delivers Strong Q2 Results and Analyst Reactions
- Alta West Mortgage Capital's Strategic Move to Acquire Premiere
- Legal Action Against Tronox Holdings: Investors Take a Stand
- Transforming Startup Success with Innovative Modeling Tools
- OUTRIGGER Enhances Family Bonds with New Grandparent Guarantee
- Explore the Exciting Features of the 2025 Mazda3 Hatchback
- Join the Fight: 2025 ZERO Prostate Cancer Run/Walk Series
- Cognizant Commits to AI Education in Nationwide Initiative
- Moore MOBILEpurpose Revolutionizes Fundraising with Texting
- Highland Copper's New Metallurgical Insights Boost Recovery Rates
- FDA's Efforts to Accelerate Approval for Rare Disease Treatments